Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Irritable Bowel Syndrome

  Free Subscription


04.03.2019

1 AAPS PharmSciTech
1 Am Fam Physician
1 Am J Physiol Gastrointest Liver Physiol
1 Cureus
1 Eur J Gastroenterol Hepatol
1 FASEB J
1 Front Cell Neurosci
1 Front Med (Lausanne)
1 Front Pediatr
1 Int J Environ Res Public Health
1 Int J Prev Med
1 JAAPA
1 Medicine (Baltimore)
1 Neurogastroenterol Motil
1 Orv Hetil
1 Pain
1 Therap Adv Gastroenterol
1 Vopr Pitan
1 World J Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AAPS PharmSciTech

  1. KOGAWA AC, Peltonen L, Antonio SG, Salgado HRN, et al
    Submission of Rifaximin to Different Techniques: Characterization, Solubility Study, and Microbiological Evaluation.
    AAPS PharmSciTech. 2019;20:125.
    PubMed     Text format     Abstract available


    Am Fam Physician

  2. WILKINSON JM, Cozine EW, Loftus CG
    Gas, Bloating, and Belching: Approach to Evaluation and Management.
    Am Fam Physician. 2019;99:301-309.
    PubMed     Text format     Abstract available


    Am J Physiol Gastrointest Liver Physiol

  3. NAKAMORI H, Naitou K, Horii Y, Shimaoka H, et al
    Medullary raphe nuclei activate the lumbosacral defecation center through the descending serotonergic pathway to regulate colorectal motility in rats.
    Am J Physiol Gastrointest Liver Physiol. 2018;314:G341-G348.
    PubMed     Text format     Abstract available


    Cureus

  4. KHETPAL N, Yadav L, Khalid S, Kumar R, et al
    Eluxadoline-induced Recurrent Pancreatitis in a Young Female without a Gallbladder: A Case Report and Literature Review.
    Cureus. 2018;10:e3747.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  5. ADEJUMO AC, Ajayi TO, Adegbala OM, Bukong TN, et al
    Higher odds of irritable bowel syndrome among hospitalized patients using cannabis: a propensity-matched analysis.
    Eur J Gastroenterol Hepatol. 2019 Feb 21. doi: 10.1097/MEG.0000000000001382.
    PubMed     Text format     Abstract available


    FASEB J

  6. MAZZONE A, Gibbons SJ, Eisenman ST, Strege PR, et al
    Direct repression of anoctamin 1 ( ANO1) gene transcription by Gli proteins.
    FASEB J. 2019 Feb 25:fj201802373R. doi: 10.1096/fj.201802373.
    PubMed     Text format     Abstract available


    Front Cell Neurosci

  7. YU YC, Li J, Zhang M, Pan JC, et al
    Resveratrol Improves Brain-Gut Axis by Regulation of 5-HT-Dependent Signaling in the Rat Model of Irritable Bowel Syndrome.
    Front Cell Neurosci. 2019;13:30.
    PubMed     Text format     Abstract available


    Front Med (Lausanne)

  8. OHKUSA T, Koido S, Nishikawa Y, Sato N, et al
    Gut Microbiota and Chronic Constipation: A Review and Update.
    Front Med (Lausanne). 2019;6:19.
    PubMed     Text format     Abstract available


    Front Pediatr

  9. CHU L, Valencia IJ, Garvert DW, Montoya JG, et al
    Onset Patterns and Course of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Front Pediatr. 2019;7:12.
    PubMed     Text format     Abstract available


    Int J Environ Res Public Health

  10. LEE TY, Hsieh TC, Sung HC, Chen WL, et al
    Internet-Delivered Cognitive Behavior Therapy for Young Taiwanese Female Nursing Students with Irritable Bowel Syndrome-A Cluster Randomized Controlled Trial.
    Int J Environ Res Public Health. 2019;16.
    PubMed     Text format     Abstract available


    Int J Prev Med

  11. JALILI M, Vahedi H, Poustchi H, Hekmatdoost A, et al
    Effects of Vitamin D Supplementation in Patients with Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Int J Prev Med. 2019;10:16.
    PubMed     Text format     Abstract available


    JAAPA

  12. KAY E, Hawramee S, Pollani S, Mandel ED, et al
    Nonpharmacologic options for treating irritable bowel syndrome.
    JAAPA. 2019;32:38-42.
    PubMed     Text format     Abstract available


    Medicine (Baltimore)

  13. SHI SM, Wen YL, Hou HB, Liu HX, et al
    Effectiveness of vitamin D for irritable bowel syndrome: A protocol for a systematic review of randomized controlled trial.
    Medicine (Baltimore). 2019;98:e14723.
    PubMed     Text format     Abstract available


    Neurogastroenterol Motil

  14. VASANT DH, Whorwell PJ
    Gut-focused hypnotherapy for Functional Gastrointestinal Disorders: Evidence-base, practical aspects, and the Manchester Protocol.
    Neurogastroenterol Motil. 2019 Feb 27:e13573. doi: 10.1111/nmo.13573.
    PubMed     Text format     Abstract available


    Orv Hetil

  15. ILIAS A, Rozsa FP, Gonczi L, Lovasz BD, et al
    [The role of fecal calprotectin in the diagnosis and treatment of gastrointestinal diseases].
    Orv Hetil. 2019;160:322-328.
    PubMed     Text format     Abstract available


    Pain

  16. BHATT RR, Gupta A, Rapkin A, Kilpatrick LA, et al
    Altered Gray Matter Volume in Sensorimotor and Thalamic Regions associated with Pain in Localized Provoked Vulvodynia: A Voxel-based Morphometry Study.
    Pain. 2019 Feb 25. doi: 10.1097/j.pain.0000000000001532.
    PubMed     Text format     Abstract available


    Therap Adv Gastroenterol

  17. MAVROUDIS G, Simren M, Jonefjall B, Ohman L, et al
    Symptoms compatible with functional bowel disorders are common in patients with quiescent ulcerative colitis and influence the quality of life but not the course of the disease.
    Therap Adv Gastroenterol. 2019;12:1756284819827689.
    PubMed     Text format     Abstract available


    Vopr Pitan

  18. GUREVICH KG, Nikonov EL, Zaborova VA, Shelekhova TY, et al
    [Probiotic using as a part of complex therapy of disbiotic violations at some intestinal diseases].
    Vopr Pitan. 2019;88:77-84.
    PubMed     Text format     Abstract available


    World J Gastroenterol

  19. ESTREMERA-AREVALO F, Barcelo M, Serrano B, Rey E, et al
    Nutrient drink test: A promising new tool for irritable bowel syndrome diagnosis.
    World J Gastroenterol. 2019;25:837-847.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: